Related Experiment Videos
Simultaneous atrial and A-V junctional tachycardia
Cardiology
|January 1, 1977
Insights
Digitalis administration can trigger simultaneous atrial and atrioventricular (AV) junctional tachycardia. Myocardial damage, anoxia, or shock increases susceptibility to these digitalis-induced arrhythmias.
Area of Science:
- Cardiology
- Clinical Electrophysiology
- Pharmacology
Background:
- Digitalis glycosides are commonly used for heart failure and arrhythmias.
- Myocardial conditions like damage, anoxia, and shock can alter cardiac sensitivity to medications.
Observation:
- Three cases of simultaneous atrial and atrioventricular (AV) junctional tachycardia were observed.
- These events occurred within a 16-month period.
Findings:
- Digitalis administration was linked to the development of these complex arrhythmias.
- Severe myocardial damage, anoxia, and shock were identified as predisposing factors.
Implications:
- Clinicians should exercise caution when prescribing digitalis to patients with compromised myocardial function.
- Understanding these risk factors is crucial for preventing digitalis-induced tachycardia.
Abstract:
Three cases of simultaneous atrial and a-v junctional tachycardia, related to the administration of digitalis and occurring in a short period of 16 months, are reported. Severe myocardial damage, anoxia and shock may decrease markedly the tolerance of the myocardium to digitalis, and thus predispose to the occurrence of simultaneous atrial and a-v junctional tachycardia.